explore -WSS

explore

author：comprehensive 2025-10-02 00:28:05 - browse：3

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Covid silver lining: Unprecedented look at human immune system

explore

knowledge

WSS

Covid silver lining: Unprecedented look at human immune system

People with mental disorders often marry others with same

Researchers test human milk's ability to repair gut microbiome

ChatGPT in medicine: STAT answers readers' burning questions

Pancreatic cancer is often deadly, but new discoveries are raising hope

Researchers test human milk's ability to repair gut microbiome

Wikipedia

explore

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Oral obesity drug from Viking Therapeutics hits key early target

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Dobbs anniversary: the lost opportunity of abortion as health care

State Dept. review finds Biden bears some blame for Afghanistan failures

Heart attack and stroke risk calculators need revising

DIEP, the 'gold standard' of breast reconstruction, is under threat

Malaria cases in Florida and Texas: Here’s what you need to know

Wikipedia

Florida Supreme Court upholds state's abortion ban

Florida Supreme Court upholds state's abortion ban

Anesthesiologist group: stop taking Ozempic before surgery

Bird flu reported in person exposed to presumably infected cattle

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare details structure of new drug price negotiation program

explore

Wikipedia

knowledge

entertainment